|
ZNF28 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.399700E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.117400E-01 |
| Normal-vs-Stage2 |
2.231000E-01 |
| Normal-vs-Stage3 |
1.332150E-02 |
| Normal-vs-Stage4 |
2.164000E-01 |
| Stage1-vs-Stage2 |
6.594400E-01 |
| Stage1-vs-Stage3 |
7.836300E-02 |
| Stage1-vs-Stage4 |
5.813200E-01 |
| Stage2-vs-Stage3 |
4.211600E-01 |
| Stage2-vs-Stage4 |
9.366800E-01 |
| Stage3-vs-Stage4 |
5.395400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.925900E-02 |
| Normal-vs-AfricanAmerican |
2.641800E-01 |
| Normal-vs-Asian |
5.735000E-01 |
| Caucasian-vs-AfricanAmerican |
9.362600E-01 |
| Caucasian-vs-Asian |
5.663200E-01 |
| AfricanAmerican-vs-Asian |
6.716600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.049900E-02 |
| Normal-vs-Female |
1.157610E-01 |
| Male-vs-Female |
3.765800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.618600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.515800E-02 |
| Normal-vs-Age(61-80Yrs) |
3.698300E-02 |
| Normal-vs-Age(81-100Yrs) |
4.090400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.252000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.517190E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.119400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.466200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.260000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.932200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.574800E-01 |
| Classical-VS-Follicular |
6.424100E-04 |
| Classical-VS-Other |
4.075400E-01 |
| Classical-VS-Normal |
5.067000E-01 |
| Tall-VS-Follicular |
7.979900E-02 |
| Tall-VS-Other |
5.192600E-01 |
| Tall-VS-Normal |
3.593600E-01 |
| Follicular-VS-Other |
7.571800E-01 |
| Follicular-VS-Normal |
1.458910E-03 |
| Other-VS-Normal |
2.108600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.968300E-02 |
| Normal-vs-N1 |
1.335430E-01 |
| N0-vs-N1 |
8.410400E-01 |
|
|
